After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NYSE listed company, ELAN falls under the Healthcare sector while operating within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Elanco Animal Health Inc is $9.11B. A total of 4.02 million shares were traded on the day, compared to an average of 7.01M shares.
In the most recent transaction, Todd S and Jennifer G Young Li bought 49,333 shares of ELAN for 16.82 per share on Aug 11 ’25. In a previous transaction on Mar 07 ’25, Kurzius Lawrence Erik bought 10,000 shares at 10.90 per share. ELAN shares that Director owns now total 101,459.
Among the insiders who bought shares, Kurzius Lawrence Erik acquired of 10,000 shares on Mar 11 ’25 at a per-share price of $10.20. This resulted in the Director holding 111,459 shares of ELAN after the transaction. In another insider transaction, HOOVER R DAVID bought 25,000 shares at $10.90 per share on Mar 05 ’25. Company shares held by the Director now total 210,000.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, ELAN has a high of $19.08 and a low of $8.02.
As of this writing, ELAN has an earnings estimate of $0.13 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of $0.14 per share and a lower estimate of $0.11. The company reported an EPS of $0.13 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. ELAN’s latest balance sheet shows that the firm has $638.00M in Cash & Short Term Investments as of fiscal 2021. There were $6.32B in debt and $1.65B in liabilities at the time. Its Book Value Per Share was $13.64, while its Total Shareholder’s Equity was $7.51B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ELAN is Buy with a score of 4.33.
